This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tabarin, A. Articles by Laurent, F. Search for Related Content PubMed PubMed Citation Articles by Tabarin, A. Articles by Laurent, F.

Usefulness of Somatostatin Receptor Scintigraphy in Patients with Occult Ectopic Adrenocorticotropin Syndrome

Department of Endocrinology (A.T., V.B.-B., B.C., P.R.), Department of Nuclear Medicine (N.V.), and Department of Radiology (F.L.), CHU de Bordeaux, Hopital Haut-Levêque, 33604 Pessac, France; Department of Endocrinology (P.C.), CHU de Bicêtre, 94275 Le Kremlin-Bicêtre, France; Department of Endocrinology (Y.B.), CHU de Grenoble, Hopital Nord, 38043 Grenoble Cedex 09, France; and Department of Internal Medicine and Endocrinology (V.R.), CHU d’Angers, 49033 Angers Cedex 01, France

Address all correspondence and requests for reprints to: Dr. A. Tabarin, Department of Endocrinology, CHU de Bordeaux, Hopital Haut-Levêque, Ave Magellan, 33604 Pessac, France. E-mail: antoine.tabarin{at}chu-aquitaine.fr

SRIF receptor scintigraphy (SRS) has been proposed for the localization of ectopic ACTH-secreting tumors responsible for Cushing’s syndrome. However, in most cases reported, the tumors were also visible using conventional imaging. Therefore, the usefulness of SRS in localizing truly occult ectopic ACTH-secreting tumors remains unknown. We report the results of SRS in 12 patients with ectopic ACTH syndrome (EAS) and in whom the source of ACTH was occult at presentation despite carefully performed conventional imaging. The diagnosis of EAS was made by identification of an ACTH-secreting tumor during follow-up in 5 patients or given a pituitary-to-peripheral ACTH ratio of 1.9 or less during petrosal sinus sampling combined with CRH injection and a negative pituitary magnetic resonance imaging (MRI). Whole-body planar SRS, using ¹¹¹In-pentetreotide, was performed 19 times in the 12 patients during initial workup and/or follow-up. Axial tomography imaging (single-photon emission-computed tomography) was performed in 7 of these. Conventional imaging was performed within a month of SRS, allowing comparison of the two approaches for the localization of the ACTH-secreting tumors. In addition, the response of plasma cortisol, after a single injection of 200 µg octreotide, was studied in 6 patients.

Five patients had negative SRS and conventional imaging studies. The source of ACTH secretion remains occult despite 10–55 months of follow-up in four of these, whereas a 2-cm ileal carcinoid tumor, with liver micrometastases, was found at laparotomy in one patient, 14 months after presentation.

SRS was positive in 4 of 12 patients. It was false-positive in 1 patient with follicular thyroid adenoma. Nineteen months after presentation, SRS identified liver metastasis that was also visible using MRI in one patient, but the primary tumor remains occult. SRS identified a 10-mm pancreatic tumor that became detectable, using computed tomography (CT) scanning 9 months later, in 1 patient; and 2 mediastinal lymph nodes of 10 mm, previously ignored by MRI, in another patient, whereas no tumor was detectable within the parenchymal lung. SRS had little influence on therapeutic options in these 2 patients, in whom no final diagnosis could be made. Repetition of SRS during the follow-up of patients with previously negative scintiscans was useless.

Conventional imaging was positive in 6 of 12 patients. In the 2 patients with pancreatic tumor and isolated mediastinal lymph nodes, conventional imaging studies were interpreted as positive only after the results of SRS. One patient had liver metastasis that was also visible using SRS. Thin-section CT scanning visualized ACTH-secreting bronchial tumors and metastatic mediastinal lymph nodes of 10–15 mm in diameter in 3 patients after 14–72 months of follow-up, whereas SRS was negative.

There was no evident relationship between the endocrine status (hyper- or eucortisolism) and the results of SRS. The in vivo response of plasma cortisol to octreotide correlated to the results of SRS in 4 of 6 cases. In conclusion, both imaging procedures had a low diagnostic yield in this series. However, the sensitivity of SRS for the detection of bronchial carcinoids was lower than that of thin-section CT scanning. We therefore advocate the use of conventional imaging, including thin-section CT scanning of the chest, analyzed by experienced radiologists, as the first-line investigation in patients with occult EAS. SRS should not be repeated during the follow-up in patients with a previously negative scintigram.

This article has been cited by other articles:

				P. Burman, A. Lethagen, K. Ivancev, L. Johansson, and A. Sundin Dual bronchial carcinoids and Cushing's syndrome with a paradoxical response to dexamethasone and a false positive outcome of inferior petrosal sinus sampling Eur. J. Endocrinol., October 1, 2008; 159(4): 483 - 488. [Abstract] [Full Text] [PDF]

				S. Dubois, O. Morel, P. Rodien, F. Illouz, S. Girault, A. Cahouet, F. Lacoeuille, M. Brousseau, J. Picquet, and V. Rohmer A Pulmonary Adrenocorticotropin-Secreting Carcinoid Tumor Localized by 6-Fluoro-[18F]L-Dihydroxyphenylalanine Positron Emission/Computed Tomography Imaging in a Patient with Cushing's Syndrome J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4512 - 4513. [Full Text] [PDF]

				C. Waintrop, F. Tenenbaum, J. Coulot, O. Vignaux, C. Blanchet, P. Legmann, B. Richard, and X. Bertagna IMAGE IN ENDOCRINOLOGY: Localization of an Occult Adrenocorticotropin-Secreting Carcinoid Tumor with Somatostatin Receptor Scintigraphy Using Single-Photon Emission Computed Tomography/Computed Tomographic Image Scanning J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3271 - 3272. [Full Text] [PDF]

				A. Markou, P. Manning, B. Kaya, S. N Datta, J. B Bomanji, and G. S Conway [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome Eur. J. Endocrinol., April 1, 2005; 152(4): 521 - 525. [Abstract] [Full Text] [PDF]

				K. Pacak, I. Ilias, C. C. Chen, J. A. Carrasquillo, M. Whatley, and L. K. Nieman The Role of [18F]Fluorodeoxyglucose Positron Emission Tomography and [111In]-Diethylenetriaminepentaacetate-D-Phe-Pentetreotide Scintigraphy in the Localization of Ectopic Adrenocorticotropin-Secreting Tumors Causing Cushing's Syndrome J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2214 - 2221. [Abstract] [Full Text] [PDF]

				S. Tsagarakis, M. Christoforaki, H. Giannopoulou, F. Rondogianni, I. Housianakou, C. Malagari, D. Rontogianni, I. Bellenis, and N. Thalassinos A Reappraisal of the Utility of Somatostatin Receptor Scintigraphy in Patients with Ectopic Adrenocorticotropin Cushing's Syndrome J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4754 - 4758. [Abstract] [Full Text] [PDF]

				P. Loli, F. Vignati, E. Grossrubatscher, P. Dalino, M. Possa, F. Zurleni, G. Lomuscio, O. Rossetti, M. Ravini, A. Vanzulli, et al. Management of Occult Adrenocorticotropin-Secreting Bronchial Carcinoids: Limits of Endocrine Testing and Imaging Techniques J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1029 - 1035. [Abstract] [Full Text] [PDF]

				C. Dall'Asta, L. Santambrogio, M. Castellani, and B. Ambrosi Difficulties in diagnosis and treatment of ectopic ACTH-producing tumors of the chest Eur. J. Cardiothorac. Surg., January 1, 2002; 21(1): 149 - 151. [Abstract] [Full Text] [PDF]

				M. Reincke, B. Allolio, W. Arlt, and C. Körber Comment on Primary Localization of an Ectopic ACTH-Producing Bronchial Carcinoid Tumor by Indium111 Pentetreotide Scintigraphy J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3399 - 3406. [Full Text]

				D. J. Torpy, C. C. Chen, N. Mullen, J. L. Doppman, J. A. Carrasquillo, G. P. Chrousos, and L. K. Nieman Primary Localization of an Ectopic ACTH-Producing Bronchial Carcinoid Tumor by Indium 111Pentetreotide Scintigraphy--Authors' Response J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3402 - 3403. [Full Text]